Vitamin D: Revision history

5 April 2024

• curprev 21:1921:19, 5 April 2024‎ Lazy talk contribs‎ 6,161 bytes +4,314‎ No edit summary

27 March 2024

• curprev 09:3709:37, 27 March 2024‎ Lazy talk contribs‎ 1,847 bytes +646‎ No edit summary
• curprev 09:3509:35, 27 March 2024‎ Lazy talk contribs‎ 1,201 bytes −69‎ No edit summary
• curprev 09:3209:32, 27 March 2024‎ Lazy talk contribs‎ 1,270 bytes +23‎ No edit summary
• curprev 09:3109:31, 27 March 2024‎ Lazy talk contribs‎ 1,247 bytes +19‎ No edit summary
• curprev 09:3109:31, 27 March 2024‎ Lazy talk contribs‎ 1,228 bytes +45‎ No edit summary

24 March 2024

• curprev 06:0306:03, 24 March 2024‎ Lazy talk contribs‎ 1,183 bytes −18‎ No edit summary

23 March 2024

• curprev 14:3014:30, 23 March 2024‎ Lazy talk contribs‎ 1,201 bytes 0‎ No edit summary
• curprev 14:2914:29, 23 March 2024‎ Lazy talk contribs‎ 1,201 bytes +2‎ No edit summary
• curprev 14:2914:29, 23 March 2024‎ Lazy talk contribs‎ 1,199 bytes +35‎ No edit summary

19 March 2024

• curprev 08:3408:34, 19 March 2024‎ Lazy talk contribs‎ 1,164 bytes +1,164‎ Created page with "{{TreatmentInfo |drug_name=Vitamin D (Alfacalcidol, Paricalcitol, Cholecalciferol variants) |FDA_approval=No |used_for=Glioblastoma Multiforme (GBM), various types of cancer |clinical_trial_phase=Various studies, including recent meta-analyses and reviews |common_side_effects=Hypercalcemia at high doses of calcitriol; other forms generally safe |OS_without=Not explicitly detailed in recent reviews |OS_with=Recent meta-analyses suggest potential for improving cancer treat..."